ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TARO Taro Pharmaceutical Industries Ltd

42.36
0.06 (0.14%)
Last Updated: 10:25:54
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,166
Bid Price
Ask Price
News -
Day High 42.39

Low
28.10

52 Week Range

High
45.76

Day Low 42.36
Company Name Stock Ticker Symbol Market Type
Taro Pharmaceutical Industries Ltd TARO NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 0.14% 42.36 10:25:54
Open Price Low Price High Price Close Price Prev Close
42.39 42.36 42.39 42.30
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
41 1,166 $ 42.38 $ 49,420 - 28.10 - 45.76
Last Trade Time Type Quantity Stock Price Currency
10:24:31 1 $ 42.33 USD

Taro Pharmaceutical Industries Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.59B 37.58M - 572.95M 25.45M 0.68 62.56
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Taro Pharmaceutical Indu... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TARO Message Board. Create One! See More Posts on TARO Message Board See More Message Board Posts

Historical TARO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week42.4142.47542.1442.2718,882-0.05-0.12%
1 Month42.3342.7042.0642.3723,0860.030.07%
3 Months42.1042.7040.4542.0938,1980.260.62%
6 Months35.5245.7635.5241.7641,9606.8419.26%
1 Year29.7945.7628.1039.5545,10112.5742.20%
3 Years71.2076.0022.8941.5028,214-28.84-40.51%
5 Years100.72102.2822.8959.9434,592-58.36-57.94%

Taro Pharmaceutical Indu... Description

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Your Recent History

Delayed Upgrade Clock